AWCI
Alpine Woods Capital Investors Portfolio holdings
AUM
$421M
This Quarter Return
+7.38%
1 Year Return
+23.18%
3 Year Return
+86.8%
5 Year Return
+147.55%
10 Year Return
+286.12%
AUM
$486M
AUM Growth
+$486M
(+6.1%)
Cap. Flow
+$2.64M
Cap. Flow
% of AUM
0.54%
Top 10 Holdings %
Top 10 Hldgs %
34.48%
Holding
274
New
27
Increased
64
Reduced
74
Closed
20
Top Buys
| 1 |
AMED
Amedisys
AMED
|
$2.08M |
| 2 |
ORBK
Orbotech Ltd
ORBK
|
$1.55M |
| 3 |
Bank OZK
OZK
|
$1.54M |
| 4 |
Centene
CNC
|
$772K |
| 5 |
Myriad Genetics
MYGN
|
$690K |
Top Sells
| 1 |
Bank of America
BAC
|
$2.95M |
| 2 |
Martin Marietta Materials
MLM
|
$1.63M |
| 3 |
General Dynamics
GD
|
$1.47M |
| 4 |
Cracker Barrel
CBRL
|
$1.13M |
| 5 |
Williams-Sonoma
WSM
|
$769K |
Sector Composition
| 1 | Healthcare | 24.3% |
| 2 | Financials | 23.64% |
| 3 | Technology | 12.53% |
| 4 | Industrials | 12.03% |
| 5 | Consumer Discretionary | 10.42% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
151
Texas Instruments
TXN
$184B
| $508K | 0.1% | 4,737 -43 | -0.9% | -$4.61K |
|
152
Royal Caribbean
RCL
$98.7B
| $503K | 0.1% | 3,869 +34 | +0.9% | +$4.42K |
|
153
Broadcom
AVGO
$1.4T
| $493K | 0.1% | 2,000 | – | – |
|
154
CMS Energy
CMS
$21.4B
| $490K | 0.1% | 10,000 -100 | -1% | -$4.9K |
|
155
Vanguard Small-Cap Growth ETF
VBK
$20.1B
| $487K | 0.1% | 2,600 | – | – |
|
156
Vanguard Growth ETF
VUG
$185B
| $483K | 0.1% | 3,000 | – | – |
|
157
American Electric Power
AEP
$59.4B
| $482K | 0.1% | 6,800 | – | – |
|
158
Vanguard Mid-Cap Growth ETF
VOT
$17.6B
| $477K | 0.1% | 3,350 +250 | +8% | +$35.6K |
|
159
Booking.com
BKNG
$181B
| $476K | 0.1% | 240 -30 | -11% | -$59.5K |
|
|
ACC
160
DELISTED
American Campus Communities, Inc.
ACC
| $460K | 0.09% | 11,170 -600 | -5% | -$24.7K |
|
|
GRUB
161
DELISTED
Just Eat Takeaway.com N.V. American Depositary Shares
GRUB
| $459K | 0.09% | +3,310 | New | +$459K |
|
|
ITCI
162
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $451K | 0.09% | 20,800 | – | – |
|
|
ABMD
163
DELISTED
Abiomed Inc
ABMD
| $450K | 0.09% | 1,000 | – | – |
|
164
CRISPR Therapeutics
CRSP
$4.71B
| $449K | 0.09% | +10,115 | New | +$449K |
|
165
Neuronetics
STIM
$220M
| $449K | 0.09% | 14,000 +4,000 | +40% | +$128K |
|
166
PVH
PVH
$4.05B
| $441K | 0.09% | 3,051 +41 | +1% | +$5.93K |
|
167
Pitney Bowes
PBI
$2.09B
| $439K | 0.09% | +62,000 | New | +$439K |
|
168
Arthur J. Gallagher & Co
AJG
$77.6B
| $428K | 0.09% | 5,750 -150 | -3% | -$11.2K |
|
169
GSK
GSK
$79.9B
| $424K | 0.09% | +10,550 | New | +$424K |
|
170
Dime Community Bancshares
DCOM
$1.35B
| $419K | 0.09% | 12,613 +4,500 | +55% | +$149K |
|
171
Microsoft
MSFT
$3.77T
| $399K | 0.08% | 3,491 | – | – |
|
172
Verastem
VSTM
$569M
| $399K | 0.08% | 55,040 | – | – |
|
173
Eagle Materials
EXP
$7.49B
| $392K | 0.08% | 4,595 -475 | -9% | -$40.5K |
|
174
Gilead Sciences
GILD
$140B
| $371K | 0.08% | 4,800 +500 | +12% | +$38.6K |
|
175
Lennox International
LII
$19.6B
| $371K | 0.08% | +1,700 | New | +$371K |
|